| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 21,510 | 21,550 | 12:37 | |
| 21,510 | 21,550 | 12:37 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 21,700 | 552 | |||
| 21,690 | 28.800 | |||
| 21,680 | 500 | |||
| 21,670 | 1.964 | |||
| 21,660 | 7.700 | |||
| 21,650 | 441 | |||
| 21,630 | 7.200 | |||
| 21,610 | 2.400 | |||
| 21,600 | 2.400 | |||
| 21,590 | 5.058 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/gs71.htm [/URL] | ||||
| 3 | 21,560 | |||
| 2.400 | 21,540 | |||
| 2.400 | 21,530 | |||
| 2.400 | 21,520 | |||
| 8.187 | 21,510 | |||
| 500 | 21,500 | |||
| 8.200 | 21,480 | |||
| 500 | 21,470 | |||
| 7.752 | 21,450 | |||
| 1.475 | 21,440 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 33.817 | 1,686 | 57.015 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 12:06:19 | 21,585 | 75 |
| 11:45:55 | 21,570 | 100 |
| 11:45:55 | 21,570 | 2 |
| 11:45:55 | 21,570 | 655 |
| 11:45:55 | 21,570 | 102 |
| 11:41:19 | 21,550 | 22 |
| 11:23:04 | 21,570 | 101 |
| 11:18:30 | 21,550 | 1.047 |
| 11:18:30 | 21,550 | 16 |
| 11:17:00 | 21,520 | 195 |
| 11:17:00 | 21,520 | 270 |
| 11:17:00 | 21,520 | 135 |
| 11:12:05 | 21,520 | 250 |
| 11:11:05 | 21,550 | 135 |
| 11:11:05 | 21,550 | 136 |
| 11:01:14 | 21,630 | 5 |
| 10:54:16 | 21,640 | 1.200 |
| 10:48:35 | 21,640 | 57 |
| 10:45:31 | 21,670 | 3 |
| 10:37:07 | 21,700 | 555 |
| Tagesumsatz Xetra | -0,300 -1,37 % | 14.864 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity | 20 | Insider Monkey | ||
| Do | GSK slammed for 'grossly misleading' and 'totally unacceptable' behavior | 15 | FiercePharma | ||
| GSK Aktie jetzt für 0€ handeln | |||||
| Do | GSK plc - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Do | GSK PLC - Director/PDMR Shareholding | 1 | RNS | ||
| Mi | GSK auf Bernstein-Gesundheitsforum: Pipeline-Wetten und KI-Offensive | 13 | Investing.com Deutsch |